Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Md Kamal Hossain, Majid Hassanzadeganroudsari & Vasso Apostolopoulos. (2020) Why METH users are at high risk of fatality due to COVID-19 infection?. Expert Review of Vaccines 19:12, pages 1101-1103.
Read now
Read now
Susan Calcaterra & IngridA. Binswanger. (2013) National Trends in Psychostimulant-Related Deaths: 1999–2009. Substance Abuse 34:2, pages 129-136.
Read now
Read now
Leo J. Schep, Robin J. Slaughter & D. Michael G. Beasley. (2010) The clinical toxicology of metamfetamine. Clinical Toxicology 48:7, pages 675-694.
Read now
Read now
Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, Muhannad Hafi & Todd Seto. (2009) Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples. Vascular Health and Risk Management 5, pages 45-52.
Read now
Read now
Gilles Fleury, Richard De La Garza$suffix/text()$suffix/text(), James J. Mahoney$suffix/text()$suffix/text(), Sarah E. Evans & Thomas F. Newton. (2008) Predictors of Cardiovascular Response to Methamphetamine Administration in Methamphetamine-Dependent Individuals. American Journal on Addictions 17:2, pages 103-110.
Read now
Read now
Shane Darke, Shane Darke, Sharlene Kaye, Shane Darke, Sharlene Kaye, Rebecca McKetin, Shane Darke, Sharlene Kaye, Rebecca McKetin, Johan Duflou, Shane Darke, Sharlene Kaye, Rebecca McKetin & Johan Duflou. (2008) Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 27:3, pages 253-262.
Read now
Read now
Articles from other publishers (104)
Joachim Neumann, Wilhelm Hußler, Karyna Azatsian, Britt Hofmann & Ulrich Gergs. (2023) Methamphetamine increases force of contraction in isolated human atrial preparations through the release of noradrenaline. Toxicology Letters 383, pages 112-120.
Crossref
Crossref
Veena Manja, Ananya Nrusimha, Ya Gao, Aleesha Sheikh, Mark McGovern, Paul A Heidenreich, Alex Tarlochan Singh Sandhu & Steven Asch. (2023) Methamphetamine-associated heart failure: a systematic review of observational studies. Heart 109:3, pages 168-177.
Crossref
Crossref
Vincenzo Somma, Michael Osekowski, Elizabeth Paratz & Yvonne Bonomo. (2023) Methamphetamine‐associated cardiomyopathy: an addiction medicine perspective. Internal Medicine Journal 53:1, pages 21-26.
Crossref
Crossref
Michael B. Stokes, Fiona Thoi, Daniel J. Scherer, Kyi T. H. Win, David M. Kaye, Karen S. Teo & Prashanthan Sanders. (2022) Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy. Journal of Cardiovascular Magnetic Resonance 24:1.
Crossref
Crossref
Yu Chen, Alexander S. Wisner, Isaac T. Schiefer, Frederick E. Williams & F. Scott Hall. (2022) Methamphetamine-induced lethal toxicity in zebrafish larvae. Psychopharmacology 239:12, pages 3833-3846.
Crossref
Crossref
Jared Tobolski, Douglas B. Sawyer, Sharon J. Song & Maxwell Eyram Afari. (2022) Cardiovascular disease associated with methamphetamine use: a review. Heart Failure Reviews 27:6, pages 2059-2065.
Crossref
Crossref
Amber N. Edinoff, Sarah E. Kaufman, Keionne M. Green, Daniel A. Provenzano, Jesse Lawson, Elyse M. Cornett, Kevin S. Murnane, Adam M. Kaye & Alan D. Kaye. (2022) Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities. Health Psychology Research 10:3.
Crossref
Crossref
Evan L. O’Keefe, Aneesh Dhore-patil & Carl J. Lavie. (2022) Early-Onset Cardiovascular Disease From Cocaine, Amphetamines, Alcohol, and Marijuana. Canadian Journal of Cardiology 38:9, pages 1342-1351.
Crossref
Crossref
Lara Curran, Gregory Nah, Gregory M. Marcus, Zian Tseng, Michael H. Crawford & Nisha I. Parikh. (2022) Clinical Correlates and Outcomes of Methamphetamine‐Associated Cardiovascular Diseases in Hospitalized Patients in California. Journal of the American Heart Association 11:16.
Crossref
Crossref
Shanqing He, Yajun Yao, Nan Yang, Youcheng Wang, Dishiwen Liu, Zhen Cao, Huiyu Chen, Yuntao Fu, Mei Yang, Songjun Wang, Guangjie He & Qingyan Zhao. (2022) Dapagliflozin Protects Methamphetamine-Induced Cardiomyopathy by Alleviating Mitochondrial Damage and Reducing Cardiac Function Decline in a Mouse Model. Frontiers in Pharmacology 13.
Crossref
Crossref
Michael Osekowski, Adam Trytell, Andre La Gerche, David Prior, Andrew MacIsaac & Elizabeth D. Paratz. (2022) A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy. American Journal of Cardiovascular Drugs 22:4, pages 385-393.
Crossref
Crossref
Keyvan M. Safdari, Curtis Converse, Fanglong Dong, Nickolas Alan MacDougall, Kevin Hyer, Alec Runyon, Haley Ahlering & Mark E. Comunale. (2022) Hemodynamic Effects of Methamphetamine and General Anesthesia. Anesthesiology Research and Practice 2022, pages 1-8.
Crossref
Crossref
Lars Unger & Matthias Hübler. 2022. Mehr Komplikationen in der Anästhesie. Mehr Komplikationen in der Anästhesie
65
78
.
Alexandra M. Stafford, Bryan K. Yamamoto & Tamara J. Phillips. (2021) Combined and sequential effects of alcohol and methamphetamine in animal models. Neuroscience & Biobehavioral Reviews 131, pages 248-269.
Crossref
Crossref
Pavan KV Reddy, Edward Chau, Sagar V Patel, Katharine Yang, Tien MH Ng & Uri Elkayam. (2021) Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction. The American Journal of Cardiology 154, pages 86-91.
Crossref
Crossref
Hicham Labazi, Margaret Nilsen & Margaret R. MacLean. (2021) Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice. European Journal of Pharmacology 900, pages 174066.
Crossref
Crossref
Alyssa Hickert, Benjamin Rowley & Marley Doyle. (2021) Perinatal Methamphetamine Use: A Review of the Literature. Psychiatric Annals 51:4, pages 189-197.
Crossref
Crossref
Chowdhury S. Abdullah, Richa Aishwarya, Shafiul Alam, Mahboob Morshed, Naznin Sultana Remex, Sadia Nitu, Gopi K. Kolluru, James Traylor, Sumitra Miriyala, Manikandan Panchatcharam, Brandon Hartman, Judy King, Mohammad Alfrad Nobel Bhuiyan, Sunitha Chandran, Matthew D. Woolard, Xiuping Yu, Nicholas E. Goeders, Paari Dominic, Connie L. Arnold, Karen Stokes, Christopher G. Kevil, A. Wayne Orr & Md. Shenuarin Bhuiyan. (2020) Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function. Communications Biology 3:1.
Crossref
Crossref
Sarah Baker & David Castle. (2020) The Cardiac Conduction and Contractility Complications of Methamphetamine Use and the Relationship to Psychiatric Comorbidity: A Systematic Review. Current Psychiatry Research and Reviews 16:1, pages 5-19.
Crossref
Crossref
Pavan K. V. Reddy, Tien M. H. Ng, Esther E. Oh, Gassan Moady & Uri Elkayam. (2020) Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review. Journal of the American Heart Association 9:11.
Crossref
Crossref
Valentin Schwarzbach, Karsten Lenk & Ulrich Laufs. (2020) Methamphetamine‐related cardiovascular diseases. ESC Heart Failure 7:2, pages 407-414.
Crossref
Crossref
Aidan (Jia Sheng) Yu, Matthew Rowe, Paul Martin & Arun Dahiya. (2020) Reversible methamphetamine-induced cardiomyopathy mimicking arrhythmogenic right ventricular cardiomyopathy with ventricular tachycardia. HeartRhythm Case Reports 6:3, pages 139-143.
Crossref
Crossref
Susan X. Zhao, Sakara Seng, Andres Deluna, Elizabeth C. Yu & Michael H. Crawford. (2020) Comparison of Clinical Characteristics and Outcomes of Patients With Reversible Versus Persistent Methamphetamine-Associated Cardiomyopathy. The American Journal of Cardiology 125:1, pages 127-134.
Crossref
Crossref
Biykem Bozkurt. 2020. Heart Failure: a Companion to Braunwald's Heart Disease. Heart Failure: a Companion to Braunwald's Heart Disease
269
287.e2
.
Christopher G. KevilNicholas E. GoedersMatthew D. WoolardMd. Shenuarin BhuiyanPaari DominicGopi K. KolluruConnie L. ArnoldJames G. TraylorA. Wayne Orr. (2019) Methamphetamine Use and Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 39:9, pages 1739-1746.
Crossref
Crossref
Krupa Merchant, Christine Schammel & James Fulcher. (2019) Acute Methamphetamine-Induced Hepatic and Pancreatic Ischemia. American Journal of Forensic Medicine & Pathology 40:3, pages 285-288.
Crossref
Crossref
Marin Nishimura, Janet Ma, Sutton Fox, Avinash Toomu, Sean Mojaver, Derek K Juang, Alan S Maisel & Isac C Thomas. (2019) Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure. The American Journal of Cardiology 124:6, pages 907-911.
Crossref
Crossref
R. Colby Passaro, Keenan Ramsey, Eddy R. Segura, Jordan E. Lake, Cathy J. Reback, Jesse L. Clark & Steve Shoptaw. (2019) Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug and Alcohol Dependence 195, pages 164-169.
Crossref
Crossref
John R. Richards, Brian N. Harms, Amanda Kelly & Samuel D. Turnipseed. (2018) Methamphetamine use and heart failure: Prevalence, risk factors, and predictors. The American Journal of Emergency Medicine 36:8, pages 1423-1428.
Crossref
Crossref
Sayaka Nagasawa, Hisako Saitoh, Shiori Kasahara, Fumiko Chiba, Suguru Torimitsu, Hiroko Abe, Daisuke Yajima & Hirotaro Iwase. (2018) Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use. Scientific Reports 8:1.
Crossref
Crossref
Yulai Shen, Lu Wu, Jun Wang, Xin Wu & Xuemei Zhang. (2018) The Role of Mitochondria in Methamphetamine-induced inhibitory effects on osteogenesis of Mesenchymal Stem Cells. European Journal of Pharmacology 826, pages 56-65.
Crossref
Crossref
Susan X. Zhao, Calvin Kwong, Aravind Swaminathan, Amit Gohil & Michael H. Crawford. (2018) Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy. JACC: Heart Failure 6:3, pages 209-218.
Crossref
Crossref
Maryam Akhgari, Homeira Mobaraki & Afshar Etemadi-Aleagha. (2017) Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. DARU Journal of Pharmaceutical Sciences 25:1.
Crossref
Crossref
Rakesh Malhotra, Shyam Patel, Tekchand Ramchand & Omar Al Nimri. (2017) Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator. Indian Pacing and Electrophysiology Journal 17:6, pages 167-170.
Crossref
Crossref
Cornel N. Stanciu, Magdalena Glass, Brian C. Muzyka & Oliver M. Glass. (2017) “Meth Mouth”: An Interdisciplinary Review of a Dental and Psychiatric Condition. Journal of Addiction Medicine 11:4, pages 250-255.
Crossref
Crossref
Stephan Schürer, Karin Klingel, Marcus Sandri, Nicolas Majunke, Christian Besler, Reinhard Kandolf, Philipp Lurz, Michael Luck, Pia Hertel, Gerhard Schuler, Axel Linke & Norman Mangner. (2017) Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy. JACC: Heart Failure 5:6, pages 435-445.
Crossref
Crossref
Meghna P. Mansukhani, Bhanu Prakash Kolla & John G. Park. (2017) Risks associated with use of stimulant medications in patients with obstructive sleep apnea and cardiomyopathy: a case-control study. Sleep Medicine 32, pages 171-175.
Crossref
Crossref
Mahsa Jafari Giv. (2016) Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC). Cardiovascular Toxicology 17:1, pages 13-24.
Crossref
Crossref
Biykem Bozkurt, Monica Colvin, Jennifer Cook, Leslie T. Cooper, Anita Deswal, Gregg C. Fonarow, Gary S. Francis, Daniel Lenihan, Eldrin F. Lewis, Dennis M. McNamara, Elfriede Pahl, Ramachandran S. Vasan, Kumudha Ramasubbu, Kismet Rasmusson, Jeffrey A. Towbin & Clyde Yancy. (2016) Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation 134:23.
Crossref
Crossref
Bita Dadpour, Vahid R. Dabbagh Kakhki, Reza Afshari, Masoumeh Dorri-giv, Seyed A.R. Mohajeri & Somayeh Ghahremani. (2016) Myocardial perfusion and left ventricular function indices assessed by gated myocardial perfusion SPECT in methamphetamine abusers. Nuclear Medicine Communications 37:12, pages 1302-1305.
Crossref
Crossref
Shaw-Hua (Anthony) Kueh, Ruvin S. Gabriel, Mayanna Lund, Tim Sutton, Joshua Bradley, Andrew J. Kerr & Jen-Li Looi. (2016) Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand. Heart, Lung and Circulation 25:11, pages 1087-1093.
Crossref
Crossref
Sean Sliman, Jill Waalen & David Shaw. (2015) Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence. Cardiovascular Toxicology 16:4, pages 381-389.
Crossref
Crossref
Robert L. PageIIII, Cindy L. O’Bryant, Davy Cheng, Tristan J. Dow, Bonnie Ky, C. Michael Stein, Anne P. Spencer, Robin J. Trupp & JoAnn Lindenfeld. (2016) Drugs That May Cause or Exacerbate Heart Failure. Circulation 134:6.
Crossref
Crossref
Michael M. Neeki, Michael Kulczycki, Jake Toy, Fanglong Dong, Carol Lee, Rodney Borger & Sasikanth Adigopula. (2016) Frequency of Methamphetamine Use as a Major Contributor Toward the Severity of Cardiomyopathy in Adults ?50?Years. The American Journal of Cardiology 118:4, pages 585-589.
Crossref
Crossref
Elizabeth D. Paratz, Neil J. Cunningham & Andrew I. MacIsaac. (2016) The Cardiac Complications of Methamphetamines. Heart, Lung and Circulation 25:4, pages 325-332.
Crossref
Crossref
Samiramis Pourmotabed & Mohammad Jalili. (2016) Pneumomediastinum following Crystal Use: A Report of Two Cases. Case Reports in Emergency Medicine 2016, pages 1-3.
Crossref
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
273
364
.
Sergio A. Salamanca, Edra E. Sorrentino, Joshua D. Nosanchuk & Luis R. Martinez. (2015) Impact of methamphetamine on infection and immunity. Frontiers in Neuroscience 8.
Crossref
Crossref
Isa KhaheshiMohammad Parsa MahjoobShooka EsmaeeliVahid EslamiHabib Haybar. (2015) Simultaneous Thrombosis of the Left Anterior Descending Artery and the Right Coronary Artery in a 34-Year-Old Crystal Methamphetamine Abuser. Korean Circulation Journal 45:2, pages 158.
Crossref
Crossref
Sarah A. Jablonski, Michael T. Williams & Charles V. Vorhees. 2016. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology
183
230
.
KA-PUI LEUNG, YI-HONG QU, DONG-FANG QIAO, WEI-BING XIE, DONG-RI LI, JING-TAO XU, HUI-JUN WANG & XIA YUE. (2014) Critical role of insulin-like growth factor binding protein-5 in methamphetamine-induced apoptosis in cardiomyocytes. Molecular Medicine Reports 10:5, pages 2306-2312.
Crossref
Crossref
Beau Abar, Linda L. LaGasse, Trecia Wouldes, Chris Derauf, Elana Newman, Rizwan Shah, Lynne M. Smith, Amelia M. Arria, Marilyn A. Huestis, Sheri DellaGrotta, Lynne M. Dansereau, Tara Wilcox, Charles R. Neal & Barry M. Lester. (2013) Cross-national Comparison of Prenatal Methamphetamine Exposure on Infant and Early Child Physical Growth: A Natural Experiment. Prevention Science 15:5, pages 767-776.
Crossref
Crossref
Christopher Tencza, Andrew Stokes & Samuel Preston. (2014) Factors responsible for mortality variation in the United States: A latent variable analysis. Demographic Research 31, pages 27-70.
Crossref
Crossref
Cher-Ming Liou, Shiow-Chwen Tsai, Chia-Hua Kuo, Timothy Williams, Hua Ting & Shin-Da Lee. (2013) Chronic Methamphetamine Exposure Induces Cardiac Fas-Dependent and Mitochondria-Dependent Apoptosis. Cardiovascular Toxicology 14:2, pages 134-144.
Crossref
Crossref
Masafumi Tomita, Hironobu Katsuyama, Yoko Watanabe, Toshiko Okuyama, Shigeko Fushimi, Takaki Ishikawa, Masayuki Nata & Osamu Miyamoto. (2014) Does methamphetamine affect bone metabolism?. Toxicology 319, pages 63-68.
Crossref
Crossref
Laura E. Halpin, Stuart A. Collins & Bryan K. Yamamoto. (2014) Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sciences 97:1, pages 37-44.
Crossref
Crossref
Sekon Won, Robert A. Hong, Ralph V. Shohet, Todd B. Seto & Nisha I. Parikh. (2013) Methamphetamine-Associated Cardiomyopathy. Clinical Cardiology 36:12, pages 737-742.
Crossref
Crossref
Laura E. Halpin, William T. GunningIIIIII & Bryan K. Yamamoto. (2013) Methamphetamine causes acute hyperthermia‐dependent liver damage. Pharmacology Research & Perspectives 1:1.
Crossref
Crossref
Annmarie Ramkissoon, Aaron M. Shapiro, Margaret M. Loniewska & Peter G. Wells. 2013. Molecular Basis of Oxidative Stress. Molecular Basis of Oxidative Stress
237
310
.
MASAFUMI TOMITA, TOSHIKO OKUYAMA, HIRONOBU KATSUYAMA, YOKO WATANABE, KOTARO SHINONE, MASAYUKI NATA & TAKAKI ISHIKAWA. (2013) Cardiotoxicity of methamphetamine under stress conditions: Comparison of single dose and long-term use. Molecular Medicine Reports 7:6, pages 1786-1790.
Crossref
Crossref
Ming Liu, Yun Wang, Han‐ming Wang, Yang Bai, Xin‐hua Zhang, Ying‐xian Sun & Huai‐liang Wang. (2013) Fluoxetine Attenuates Chronic Methamphetamine‐induced Pulmonary Arterial Remodelling: Possible Involvement of Serotonin Transporter and Serotonin 1B Receptor. Basic & Clinical Pharmacology & Toxicology 112:2, pages 77-82.
Crossref
Crossref
Omid Mehrpour. (2012) Methamphetamin abuse a new concern in Iran. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Crossref
Roxana Sadeghi, Khosro Agin, Maryam Taherkhani, Leila Najm-Afshar, Lewis S Nelson, Mohammad Abdollahi & Shahin Shadnia. (2012) Report of methamphetamine use and cardiomyopathy in three patients. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Crossref
Laura E. Halpin & Bryan K. Yamamoto. (2012) Peripheral Ammonia as a Mediator of Methamphetamine Neurotoxicity. The Journal of Neuroscience 32:38, pages 13155-13163.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
1
56
.
David Vearrier, Michael I. Greenberg, Susan Ney Miller, Jolene T. Okaneku & David A. Haggerty. (2012) Methamphetamine: History, Pathophysiology, Adverse Health Effects, Current Trends, and Hazards Associated with the Clandestine Manufacture of Methamphetamine. Disease-a-Month 58:2, pages 38-89.
Crossref
Crossref
Reginald P. Sequeira. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
1
16
.
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse
371
453
.
SHANE DARKE, MICHELLE TOROK, SHARLENE KAYE & JOHAN DUFLOU. (2010) Cardiovascular disease risk factors and symptoms among regular psychostimulant users. Drug and Alcohol Review 29:4, pages 371-377.
Crossref
Crossref
K. C. Lord, S. K. Shenouda, E. McIlwain, D. Charalampidis, P. A. Lucchesi & K. J. Varner. (2010) Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovascular Research 87:1, pages 111-118.
Crossref
Crossref
Todd A. Sheer, Elliot Joo & Bruce A. Runyon. (2010) Usefulness of Serum N-terminal–ProBNP in Distinguishing Ascites Due to Cirrhosis From Ascites Due to Heart Failure. Journal of Clinical Gastroenterology 44:1, pages e23-e26.
Crossref
Crossref
Reginald P. Sequeira. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
1
28
.
Yi Shao Hua, Ren Liang, Liu Liang & Guang Zhao Huang. (2009) Contraction Band Necrosis in Two Ecstasy Abusers. American Journal of Forensic Medicine & Pathology 30:3, pages 295-297.
Crossref
Crossref
Subat Turdi, Robbie M. Schamber, Nathan D. Roe, Herbert G. ChewJr.Jr., Bruce Culver & Jun Ren. (2009) Acute methamphetamine exposure inhibits cardiac contractile function. Toxicology Letters 189:2, pages 152-158.
Crossref
Crossref
Christopher C. Cruickshank & Kyle R. Dyer. (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:7, pages 1085-1099.
Crossref
Crossref
Antony Leslie Innasimuthu, Rajiv Sankarnarayanan, Gopala Krishna B. Rao & Rob S. Hornung. (2009) An unusual cause of breathlessness in a young man. Canadian Journal of Cardiology 25:6, pages 369-371.
Crossref
Crossref
Hiroki Ito, Khung‐Keong Yeo, Mevan Wijetunga, Todd B. Seto, Kevin Tay & Irwin J. Schatz. (2009) A Comparison of Echocardiographic Findings in Young Adults With Cardiomyopathy: With and Without a History of Methamphetamine Abuse. Clinical Cardiology 32:6.
Crossref
Crossref
Wakako Hikiji, Keiko Kudo, Shinji Sato, Yosuke Usumoto, Akiko Tsuji & Noriaki Ikeda. (2008) False negative result for amphetamines on the Triage? Drug of Abuse panel?. International Journal of Legal Medicine 123:3, pages 247-252.
Crossref
Crossref
Mohammed Nasimul Islam, Jesmine Khan & Hasnan Jaafar. (2009) Leave Methamphetamine to be alive ? Part II. Legal Medicine 11, pages S143-S146.
Crossref
Crossref
Bernard Cartigny, Jean François Wiart, Camille Richeval, Nathalie Azaroual, Michel Imbenotte, Luc Humbert, Gaston Vermeersch & Michel Lhermitte. (2009)
Intoxication fatale par le carbofurane et le métaldéhyde : analyse par spectroscopie RMN
1
H et par CLHP-SM
. Annales de Toxicologie Analytique 21:3, pages 159-165.
Crossref
Crossref
Steven B. Karch. 2009. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law
315
325
.
Steven Karch. 2008. Karch's Pathology of Drug Abuse, Fourth Edition. Karch's Pathology of Drug Abuse, Fourth Edition
261
311
.
Elizabeth Hausner, Monica L Fiszman, Joseph Hanig, Patricia Harlow, Gwen Zornberg & Solomon Sobel. (2008) Long-Term Consequences of Drugs on the Paediatric Cardiovascular System. Drug Safety 31:12, pages 1083-1096.
Crossref
Crossref
Shao-hua Yi, Liang Ren, Tian-tong Yang, Liang Liu, Han Wang & Qian Liu. (2008) Myocardial lesions after long-term administration of methamphetamine in rats. Chinese Medical Sciences Journal 23:4, pages 239-243.
Crossref
Crossref
Deborah B. Diercks, Gregg C. Fonarow, J. Douglas Kirk, Preeti Jois-Bilowich, Judd E. Hollander, Jim Edward Weber, Janet Wynne, Roger M. Mills, Clyde Yancy & W. Franklin PeacockIVIV. (2008) Illicit Stimulant Use in a United States Heart Failure Population Presenting to the Emergency Department (from the Acute Decompensated Heart Failure National Registry Emergency Module). The American Journal of Cardiology 102:9, pages 1216-1219.
Crossref
Crossref
Sharlene Kaye, Shane Darke, Johan Duflou & Rebecca McKetin. (2008) Methamphetamine‐related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 103:8, pages 1353-1360.
Crossref
Crossref
S. K. Shenouda, K. C. Lord, E. McIlwain, P. A. Lucchesi & K. J. Varner. (2008) Ecstasy produces left ventricular dysfunction and oxidative stress in rats. Cardiovascular Research 79:4, pages 662-670.
Crossref
Crossref
Arthur N. Westover, Paul A. Nakonezny & Robert W. Haley. (2008) Acute myocardial infarction in young adults who abuse amphetamines. Drug and Alcohol Dependence 96:1-2, pages 49-56.
Crossref
Crossref
Katarzyna Mizia-Stec, Zbigniew G?sior, Romuald Wojnicz, Maciej Haberka, Marcin Mielczarek, Andrzej Wierzbicki, Katarzyna Pstra?Marek Hartleb. (2008) Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovascular Pathology 17:4, pages 250-253.
Crossref
Crossref
K. Berger, M.-C. H?rault, V. Danel, F. Vincent & C. Jacquot. (2008) Choc cardiog?nique apr?s ingestion d?amph?tamines sur un terrain de myocardite ? Mycoplasme. Annales Fran?aises d'Anesth?sie et de R?animation 27:3, pages 256-260.
Crossref
Crossref
Sundararajan Srikanth, Rajat Barua & John Ambrose. (2008) Methamphetamine-Associated Acute Left Ventricular Dysfunction: A Variant of Stress-Induced Cardiomyopathy. Cardiology 109:3, pages 188-192.
Crossref
Crossref
Steven Karch. 2007. Pathology, Toxicogenetics, and Criminalistics of Drug Abuse. Pathology, Toxicogenetics, and Criminalistics of Drug Abuse
115
122
.
Tomoko Miyashita, Takahito Hayashi, Yuko Ishida, Kouichi Tsuneyama, Akihiko Kimura & Toshikazu Kondo. (2007) A fatal case of pontine hemorrhage related to methamphetamine abuse. Journal of Forensic and Legal Medicine 14:7, pages 444-447.
Crossref
Crossref
Sharlene Kaye, Rebecca McKetin, Johan Duflou & Shane Darke. (2007) Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102:8, pages 1204-1211.
Crossref
Crossref
Khung-Keong Yeo, Mevan Wijetunga, Hiroki Ito, Jimmy T. Efird, Kevin Tay, Todd B. Seto, Kavitha Alimineti, Chieko Kimata & Irwin J. Schatz. (2007) The Association of Methamphetamine Use and Cardiomyopathy in Young Patients. The American Journal of Medicine 120:2, pages 165-171.
Crossref
Crossref
Paul A. Grayburn & Eric J. Eichhorn. 2007. Cardiovascular Medicine. Cardiovascular Medicine
2357
2369
.
Charles Wetli. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
71
145
.
Mark Toles, Caroline S. Jiang, Deborah Goebert & Louise Lettich. (2006) Methamphetamine in Emergency Psychiatry. Addictive Disorders & Their Treatment 5:4, pages 191-199.
Crossref
Crossref
Werner Jacobs. (2006) Fatal Amphetamine-Associated Cardiotoxicity and Its Medicolegal Implications. The American Journal of Forensic Medicine and Pathology 27:2, pages 156-160.
Crossref
Crossref
J. W. ShanerN. KimmesT. SainiP. Edwards. (2006) "Meth Mouth": Rampant Caries in Methamphetamine Abusers. AIDS Patient Care and STDs 20:3, pages 146-150.
Crossref
Crossref
Timothy W. Lineberry & J. Michael Bostwick. (2006) Methamphetamine Abuse: A Perfect Storm of Complications. Mayo Clinic Proceedings 81:1, pages 77-84.
Crossref
Crossref
Aaron B. Schneir & Richard F. Clark. 2006. Sudden Deaths in Custody. Sudden Deaths in Custody
81
97
.
Manish M. Patel, Martin G. Belson, David Wright, Huang Lu, Michael Heninger & Michael A. Miller. (2005) Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: An autopsy study. Resuscitation 66:2, pages 197-202.
Crossref
Crossref
Jane Carlisle Maxwell. (2005) Emerging research on methamphetamine. Current Opinion in Psychiatry 18:3, pages 235-242.
Crossref
Crossref